1. Home
  2. ITOS vs BWFG Comparison

ITOS vs BWFG Comparison

Compare ITOS & BWFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • BWFG
  • Stock Information
  • Founded
  • ITOS 2011
  • BWFG 2002
  • Country
  • ITOS United States
  • BWFG United States
  • Employees
  • ITOS N/A
  • BWFG N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • BWFG Major Banks
  • Sector
  • ITOS Health Care
  • BWFG Finance
  • Exchange
  • ITOS Nasdaq
  • BWFG Nasdaq
  • Market Cap
  • ITOS 381.2M
  • BWFG 273.2M
  • IPO Year
  • ITOS 2020
  • BWFG N/A
  • Fundamental
  • Price
  • ITOS $9.99
  • BWFG $36.21
  • Analyst Decision
  • ITOS Hold
  • BWFG Buy
  • Analyst Count
  • ITOS 6
  • BWFG 2
  • Target Price
  • ITOS $10.60
  • BWFG $42.00
  • AVG Volume (30 Days)
  • ITOS 1.0M
  • BWFG 16.9K
  • Earning Date
  • ITOS 08-07-2025
  • BWFG 07-23-2025
  • Dividend Yield
  • ITOS N/A
  • BWFG 2.21%
  • EPS Growth
  • ITOS N/A
  • BWFG N/A
  • EPS
  • ITOS N/A
  • BWFG 1.62
  • Revenue
  • ITOS $35,000,000.00
  • BWFG $69,109,000.00
  • Revenue This Year
  • ITOS N/A
  • BWFG $59.47
  • Revenue Next Year
  • ITOS N/A
  • BWFG $13.75
  • P/E Ratio
  • ITOS N/A
  • BWFG $22.39
  • Revenue Growth
  • ITOS 177.89
  • BWFG N/A
  • 52 Week Low
  • ITOS $4.80
  • BWFG $22.80
  • 52 Week High
  • ITOS $18.13
  • BWFG $40.21
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 62.26
  • BWFG 60.82
  • Support Level
  • ITOS $9.91
  • BWFG $35.30
  • Resistance Level
  • ITOS $10.20
  • BWFG $35.75
  • Average True Range (ATR)
  • ITOS 0.16
  • BWFG 0.72
  • MACD
  • ITOS -0.12
  • BWFG 0.01
  • Stochastic Oscillator
  • ITOS 13.56
  • BWFG 77.98

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About BWFG Bankwell Financial Group Inc.

Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.

Share on Social Networks: